Cervical cancer prevention in China: where are we now, and what’s next?

References

1. 1.↵
   Global Cancer Observatory: Cancer Today. https://gco.iarc.fr/today.
2. 2.↵
   2. Maomao C,
   3. He L,
   4. Dianqin S,
   5. Siyi H,
   6. Xinxin Y,
   7. Fan Y, et al.

   Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med. 2022; 19: 1121–38.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   2. Qiu H,
   3. Cao S,
   4. Xu R.

   Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021; 41: 1037–48.

   OpenUrl
4. 4.↵
   2. Zheng R,
   3. Zhang S,
   4. Zeng H,
   5. Wang S,
   6. Sun K,
   7. Chen R, et al.

   Cancer incidence and mortality in China, 2016. J Natl Cancer Center. 2022; 2: 1–9.

   OpenUrl
5. 5.↵
   2. Li X,
   3. Zheng R,
   4. Li X,
   5. Shan H,
   6. Wu Q,
   7. Wang Y, et al.

   Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014. Chin J Cancer Res. 2017; 29: 477–86.

   OpenUrlCrossRef
6. 6.↵
   Cervical Cancer Elimination Initiative. Available from https://www.who.int/initiatives/cervical-cancer-elimination-initiative.
7. 7.↵
   Global strategy to accelerate the elimination of cervical cancer as a public health problem. Available from https://www.who.int/publications/i/item/9789240014107.
8. 8.↵
   A cervical cancer-free future: First-ever global commitment to eliminate a cancer. Available from https://www.who.int/news/item/17-11-2020-a-cervical-cancer-free-future-first-ever-global-commitment-to-eliminate-a-cancer.
9. 9.↵
   Human Papillomavirus (HPV) vaccination coverage. Available from https://who-wiise-frontend-prod.azurewebsites.net/pages/coverage/hpv.html.
10. 10.↵
    2. Yifan S,
    3. Xiaoxue L,
    4. Zundong Y,
    5. Wenzhou Y,
    6. Lei C,
    7. Lingshen C, et al.

    Human papillomavirus vaccine coverage among the 9-45 year-old female population of China in 2018-2020. Chin J Vaccines Immun. 2021; 27: 570–5.

    OpenUrl
11. 11.↵
    2. Liu J,
    3. Wu L,
    4. Bai Q,
    5. Ren J,
    6. Shao H,
    7. Huang Z.

    Surveillance for coverage of human papillomavirus (HPV) vaccine and adverse events following immunization with HPV vaccine in Shanghai, 2017-2019. Chin J Vaccines Immun. 2020; 26: 322–5.

    OpenUrl
12. 12.↵
    2. Chen W,
    3. Li Y,
    4. Wu X,
    5. Zhang Y,
    6. Di Z.

    Human Papilloma vaccine coverage among age-eligible women in Tianjin from 2018 to 2021. Chin J Vaccines Immun. 2022; 28: 684–9.

    OpenUrl
13. 13.↵
    2. Rositch AF,
    3. Liu T,
    4. Chao C,
    5. Moran M,
    6. Beavis AL.

    Levels of parental human papillomavirus vaccine hesitancy and their reasons for not intending to vaccinate: insights from the 2019 National Immunization Survey-Teen. J Adolesc Health. 2022; 71: 39–46.

    OpenUrl
14. 14.↵
    2. Yin X,
    3. Zhang M,
    4. Wang F,
    5. Huang Y,
    6. Niu Y,
    7. Ge P, et al.

    A national cross-sectional study on the influencing factors of low HPV vaccination coverage in mainland China. Front Public Health. 2022: 10: 1064802.
15. 15.↵
    2. Bruni L,
    3. Serrano B,
    4. Roura E,
    5. Alemany L,
    6. Cowan M,
    7. Herrero R, et al.

    Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Global Health. 2022; 10: e1115–27.

    OpenUrl
16. 16.↵
    2. Zhang M,
    3. Zhong Y,
    4. Wang L,
    5. Bao H,
    6. Huang Z,
    7. Zhao Z, et al.

    Cervical cancer screening coverage - China, 2018-2019. China CDC Wkly. 2022; 4: 1077–82.

    OpenUrlCrossRef
17. 17.↵
    2. Liu Y,
    3. Guo J,
    4. Zhu G,
    5. Zhang B,
    6. Feng XL.

    Changes in rate and socioeconomic inequality of cervical cancer screening in northeastern China from 2013 to 2018. Front Med (Lausanne). 2022; 9: 913361.
18. 18.↵
    WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions. Available from https://www.who.int/publications/i/item/9789241550598.
19. 19.↵
    2. Xue P,
    3. Ng MTA,
    4. Qiao Y.

    The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence. BMC Med. 2020; 18: 169.

    OpenUrl